recent updat model primarili reflect divestitur dental
envista time pend acquisit given number
move part relat aforement dynam recent investor inbound
publish report highlight key chang model pleas click click
read access full report
reduc revenu estim forecast revenu
reduct driven sole remov dental/envista
forecast addit updat model reflect restat histor
financi releas decemb chang core revenu growth
forecast
reduc revenu estim primarili reflect
remov dental/envista result time acquisit
addit reduc core revenu growth forecast
reflect early-in-the-year conservat forecast report revenu
reduc ep estim forecast ep
reduct primarili driven remov dental/envista result
lesser extent increment interest expens debt rais
reduc ep estim reflect lower revenu
forecast howev offset revenu cut detail list follow
continu view core long-term tool hold share trade
premium peer pro forma ev/ebitda basi share trade
line peer p/fcf basi importantli key pillar
invest thesi remain much intact attract high-qual busi portfolio
acceler revenu growth top tier manag team long-term driven
upsid also note appear posit sustain revenu
growth busi rel safeti name tool group expect compani
post peer group averag growth throughout econom cycl
near-term expect share outperform compani execut well
ge biopharma integr see limit risk miss expect addit
believ pay debt rapidli net debt/ebitda
end posit resum meaning capit deploy
month price target increas earlier today base
premium peer
pleas see page report import disclosur
remain enthus long-term outlook particularli subsequ ge
biopharma deal appear well-posit gener sustain revenu
growth ep growth expect continu deploy capit tuck-in
acquisit near term expect compani posit complet larger
ep upsid year
ep upsid year
capit deploy drive ep
diversifi multi-industri compani signific presenc health
care environment test manufactur market becom
focus tool diagnost compani divestitur juli
envista dental decemb subsequ acquisit
full divestitur dental segment total revenu expect gener
life scienc diagnost market danah histor success larg
function strong manag team danah busi system db oper disciplin
updat revenu estim reflect number
dynam list chart note reduc organ
revenu growth forecast chang list chart
sum due round rational found outlook report
compani report thomson eikon cowen compani
updat revenu estim reflect number
dynam list chart
compani report thomson eikon cowen compani
cowen remov dental/envista result less quarter ge ge biopharma deal close end prior forecast assum begin close ge-rel divestitur certain product sartoriu reduct core reflect early-in-th year conservat see outlook report publish todaycurr cowen consensu appear sell-sid estim complet updat reflect aforement cowen remov dental/envista result increment debt/interest rais debt intra-quart embed guidanc larg contempl prior forecast less quarter ge ge biopharma deal close end prior forecast assum begin close ge-rel divestituresn/alimitedlimit impact ep addit lower interest rate potenti off-set explicitli model reduct core growthn/alimitedlimit impact ep addit lower interest rate potenti off-set explicitli model dental/envista remov dental/envista result lower share time envista split-off benefici impact result limit reduc share count cowen consensu appear sell-sid estim complet updat reflect aforement dynam cowen
price target base sever methodolog may includ analysi market risk
group ev/ebitda premium discount averag group price-to-earnings sum part net asset
valu dividend return return equiti roe next month
risk medic life scienc tool sector may includ reduct delay research
develop budget govern fund reduc delay purchas
health care hospit custom increas extend regulatori hurdl process
regul product increas depend volatil emerg market revenu
profit gener macroeconom challeng
make invest recommend earli stage pre-commerci ls dt
compani base upon assess technolog probabl market success
competit regulatori reimburs etc potenti market opportun
event success howev compani lack tradit and/or matur
financi metric believ good methodolog assign specif
target price stock
downsid risk includ limit macroeconom deterior
current level inabl execut integr eros market share price
due competit inabl deliv margin target value-destruct
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
cowen compani llc affili make market stock danah corpor thermo fisher scientif secur
cowen compani llc manag co-manag public offer past month
cowen compani llc receiv compens invest bank servic past month
past month client cowen compani llc cowen compani llc provid provid invest bank
servic past month
cowen compani llc compens research analyst activ servic intend benefit firm investor client individu compens determin research
analyst includ author report base varieti factor includ overal profit firm total revenu deriv sourc includ
revenu invest bank sale trade princip trade revenu cowen compani llc compens research analyst base specif invest
bank transact specif sale trade princip trade revenu
research report simultan avail client client websit research report client research report dissemin e-mail
made avail third-parti aggreg cowen compani llc respons redistribut research third parti aggreg select research report
avail print form addit electron form publish research report obtain firm client websit http //cowenlibrari bluematrix com/client/
inform opinion estim forecast date report subject chang without prior notif seek updat research appropri
variou regul may prevent us research report publish irregular interv appropri analyst judgement
inform subject secur may obtain offic research report publish sole inform purpos constru offer
sell solicit offer buy secur state offer solicit would illeg disclosur relat cowen compani llc
inform herein base sourc believ reliabl guarante us purport complet statement summari avail data
opinion express herein statement judgment date subject chang without notic opinion recommend herein take
account individu client circumst object need intend recommend invest strategi recipi report must make
independ decis regard secur subject research report case secur financi instrument may difficult valu sell reliabl
inform valu risk relat secur financi instrument may difficult obtain extent report discuss legal proceed issu
prepar express intend express legal conclus opinion advic salespeopl trader profession may provid oral written
market commentari trade strategi client reflect opinion contrari opinion express research princip trade area invest
busi may make invest decis inconsist recommend view express research cowen compani llc maintain physic electron
procedur inform barrier address flow inform among depart within cowen compani llc order prevent avoid conflict
interest respect analyst recommend
import disclosur regard compani subject research report pleas contact complianc depart cowen compani llc lexington
avenu floor new york ny addit import disclosur except valuat method risk avail firm disclosur
websit http //cowen bluematrix com/sellside/disclosur action
equiti research price target cowen compani llc assign price target compani cover equiti research unless note otherwis equiti research price target
issuer stock repres valu analyst reason expect stock reach perform period twelv month price target equiti secur
report consid context prior publish cowen compani llc equiti research report includ disclosur equiti report
firm disclosur websit may may includ equiti research price target well develop relat issuer industri financi market
equiti research price target valuat methodolog risk associ achiev given equiti research price target pleas see analyst equiti research report
publish target
cowen cross-asset research due natur fix incom market issuer debt secur issuer discuss cowen cross-asset research report
assign rate price target may continu follow accordingli investor must regard brand report provid stand-alon analysi reflect
analyst opinion date report expect continu analysi addit report relat issuer debt secur issuer
time time cowen cross-asset research analyst provid invest recommend secur subject report recommend intend
time date public within paramet specifi individu report cowen cross-asset research invest recommend made
strictli case-by-cas basi recommend provid part overarch rate system set consist appli benchmark view express
cross-asset research report may differ view offer firm equiti research report prepar client
notic uk investor public produc cowen compani llc regul unit state finra commun person kind
describ articl servic market act promot order must transmit person without
notic european union investor individu produc recommend requir obtain certain licens financi regulatori author finra review
author current licens statu histori employ histori report regulatori custom disput crimin matter via brokercheck finra http //
brokercheck finra org/ individu licens statu finra constru endors finra gener biograph inform also avail
research analyst www cowen com
addit complet preced recommend histori relat recommend research report avail http //cowen bluematrix com/sellside/
recommend contain report produc januari et dissemin januari et
copyright user agreement gener inform relat report
cowen compani llc right reserv member nyse finra sipc research report prepar exclus use cowen client may
reproduc display modifi distribut transmit disclos whole part form manner other outsid organ without express prior
written consent cowen cowen research report distribut simultan client elig receiv research report unauthor use disclosur
